| Literature DB >> 27847970 |
Nikolaus A Haas1,2, Laura Kock3, Harald Bertram4, Regina Boekenkamp5, Daniel De Wolf6, Igor Ditkivskyy7, Matthias W Freund8, Marc Gewillig9, Christoph M Happel3, Ulrike Herberg10, Edvard Karthasyan11, Rainer Kozlik-Feldmann12, Oliver Kretschmar13, Yulia Kuzmenko14, Ornella Milanesi15, Goetz Mueller16, Giacomo Pongiglione17, Stephan Schubert18, Gleb Tarusinov19, Christoph Kampmann20.
Abstract
In August 2010, the Nit-Occlud® Lê (EUREVECO) became available for transcatheter coil occlusion of ventricular septal defects (VSDs). Retrospective European Registry for VSD Closure using the Nit-Occlud® Lê-VSD-Coil; analysis of the feasibility, results, safety and follow-up of VSD-closure over a 3-year period in 18 European centers. In 102 of 111 patients (female 66), successful VSD closure was performed (mean age 8.2 years, mean weight 28.82 kg), 81 perimembranous VSDs (48 with aneurysm), 30 muscular VSDs, mean procedure time was 121.1 min, and mean fluoroscopy time was 26.3 min. Short- and midterm term follow-up was possible in 100/102 patients, there was 1 embolization and 1 explantation after 24 months. Immediate complete closure occurred in 49 of 101 patients (48.5%), trivial residual shunt was present in 51 (50.0%), closure rate was 95% after 6 months and 97% after 1 year. Out of the 102 patients, there were 2 severe complications (1.8%) (1 severe hemolysis, 1 embolization) and 8 moderate/transient (=7.2%) including 1 transient AV block. During a mean follow-up period of 31.3 months (range 24-48) and a total follow-up time of 224.75 patient years, no further problems occurred. VSD closure with the Nit-Occlud® Lê VSD coil is feasible and safe with a minimal risk of severe side effects. The long-term effects and safety require further clinical follow-up studies.Entities:
Keywords: Congenital heart defects; EUREVECO; Interventional VSD closure; Muscular VSD; Nit-Occlud® Lê-VSD-Coil; Perimembranous VSD
Mesh:
Year: 2016 PMID: 27847970 DOI: 10.1007/s00246-016-1502-8
Source DB: PubMed Journal: Pediatr Cardiol ISSN: 0172-0643 Impact factor: 1.655